|1.||Warf, Benjamin C: 11 articles (04/2015 - 12/2005)|
|2.||Mizuno, Yoshikuni: 9 articles (01/2006 - 02/2002)|
|3.||Stewart, Bernal: 7 articles (09/2015 - 01/2009)|
|4.||Charles, Christine Ann: 6 articles (08/2015 - 07/2009)|
|5.||Anversa, Piero: 6 articles (01/2015 - 07/2006)|
|6.||Mori, Hideo: 6 articles (01/2006 - 02/2002)|
|7.||Callaway, Clifton W: 5 articles (08/2015 - 08/2011)|
|8.||Mugamba, John: 5 articles (04/2015 - 10/2011)|
|9.||Reyes, Eduardo: 5 articles (01/2015 - 01/2014)|
|10.||Fuentealba, Cynthia: 5 articles (01/2015 - 01/2014)|
06/01/2013 - "The alcohol-free EO mouthrinse demonstrated superior efficacy in reducing plaque and gingivitis over 6 months compared to both negative control and alcohol-free CPC mouthrinse."
09/01/2015 - "The benefits of including CPC in this new formulation are demonstrated by in vitro and clinical studies which demonstrate the efficacy of this formulation of CPC on biofilm as well as an effect on the reduction of plaque and gingivitis in three clinical studies."
01/01/2013 - "These in vitro and ex-vivo studies provide a biological rationale for previous clinical studies demonstrating the efficacy of CPC mouthrinses in reducing supragingival plaque and plaque-associated gingivitis."
01/01/2009 - "As measurements were conducted 12 hours after product use, the results also demonstrate that the 0.5% CPC mouthrinse provides 12-hour protection against plaque and gingivitis."
06/01/2010 - "This study demonstrated the superiority of an EO rinse compared to a 0.05% CPC rinse in reducing plaque and gingivitis and confirmed that the daily use of an EO containing mouthrinse can provide a clinically significant benefit in reducing plaque and gingivitis."
01/01/2009 - "The overall results from this double-blind clinical study support the conclusion that, after seven days of product use, a mouthrinse containing 0.05% CPC provides significantly greater efficacy in preventing dental plaque build-up than a control mouthrinse without 0.05% CPC. "
01/01/2009 - "The overall results of this double-blind clinical study support the conclusion that after seven days of product use, a mouthrinse containing 0.05% CPC provides significantly greater efficacy for reducing dental plaque 12 hours after use, than does a control mouthrinse without 0.05% CPC."
01/01/2009 - "The objective of this independent, double-blind, seven-day clinical study was to assess the efficacy of a commercially available mouthrinse containing 0.05% CPC for controlling dental plaque relative to that of a control mouthrinse without 0.05% CPC. "
01/01/2009 - "As measurements were made 12 hours after final product use, the results also demonstrate that the CPC rinse provides 12-hour protection against dental plaque build-up."
10/01/2014 - "0.05% CPC mouthwash can be an alternative to CHX mouthwash since it is alcohol free and found as efficient as CHX in dental plaque reduction with lesser side effects. "
02/01/2013 - "The combination of ETV and choroid plexus cauterization (ETV/CPC) has improved the success rate among infants with hydrocephalus for whom ETV alone is much less successful. "
09/01/2014 - "Endoscopic CPC with or without ETV can be a safe and effective treatment alternative to shunt placement in infantile hydrocephalus. "
05/01/2015 - "The authors sought to investigate the efficacy of combining ETV and CPC (ETV+CPC) in treating childhood hydrocephalus in Nigeria. "
06/01/2013 - "This study is the first to report long-term success of ETV +/- choroid plexus cauterization (CPC) for infants with congenital idiopathic hydrocephalus (CIH). "
01/01/2013 - "This study aims to review the role of choroid plexus coagulation (CPC) for hydrocephalus not due to CSF overproduction. "
08/01/2013 - "TD-CPC was effective in the short term as IOP lowering therapy in a pediatric patient with refractory uveitic glaucoma. "
03/01/2014 - "CPC is a safe and effective procedure that should be considered if medical treatment has failed to control glaucoma in FUS."
12/01/2015 - "To evaluate long-term efficacy of a second glaucoma drainage device (GDD) versus cyclophotocoagulation (CPC) after failure of primary drainage implant. "
03/01/2014 - "The goal of this study was to assess the efficacy and safety of cyclophotocoagulation (CPC) in the management of glaucoma secondary to FUS. "
04/01/2015 - "An alternative interventional treatment of glaucoma is the cyclophotocoagulation (CPC). "
|5.||Heart Arrest (Cardiac Arrest)
02/01/2009 - "Outcome was measured by neurologic exam 6 months after cardiac arrest with good outcome defined as a Cerebral Performance Category (CPC) of 1 or 2. In multiple logistic regression analysis, age (odds ratio [OR], 95% confidence interval 1.1 [1.03-1.18]/year), NSE at 48 h (OR 1.1 [1.02-1.26]/microg/l), and increase in NSE levels (OR 7.2 [1.7-31.3]) were predictors of poor outcome, but the OHCA score was not. "
09/01/2012 - "All patients who did not have cardiac arrest recovered and were discharged with CPC 1. In this study, outcomes in unconscious near-hanging patients with cardiac arrest were poor despite treatment with TH. "
08/01/2015 - "The objective was to identify predictors of survival free from significant neurological sequelae (Cerebral Performance Categories Scale (CPC): >2) six months after cardiac arrest. "
03/01/2015 - "We prospectively enrolled 33 survivors of cardiac arrest, with cerebral performance categories (CPC) 1 and 2 and a control-group (n=33) matched in sex, age and educational-level. "
01/01/2015 - "Global measures of disability indicated recovery between one month and one year after cardiac arrest (mean CPC: 2.1 versus 1.69, P < 0.05; mean mRS: 2.55 versus 1.83, P < 0.05). "
|1.||Cetylpyridinium (Cetylpyridinium Chloride)
|5.||Sodium Fluoride (Ossin)
|7.||3- (2- carboxypiperazin- 4- yl)propyl- 1- phosphonic acid (CPP)
|9.||Sodium Chloride (Saline Solution)
|10.||Sodium Hydroxide (Caustic Soda)
|1.||Transplantation (Transplant Recipients)
|5.||Drug Therapy (Chemotherapy)